Abstract
The invention relates to a microbiome-based therapeutic composition comprising an engineered probiotic cell expressing a sulfotransferase and the use of the microbiome-based therapeutic composition in medicine and a therapeutic regimen.
| Original language | English |
|---|---|
| IPC | C12R 1/ 85 A N |
| Patent number | WO2022161936 |
| Filing date | 26/01/2021 |
| Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 26/01/2021 |
| Priority number | EP20210153446 |
| Publication status | Published - 4 Aug 2022 |